{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:27:44Z","timestamp":1790684864739,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European TRANS-INT Consortium"},{"name":"European Union's Seventh Framework Programme","award":["281035"],"award-info":[{"award-number":["281035"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jconrel.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T04:05:48Z","timestamp":1520309148000},"page":"125-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy"],"prefix":"10.1016","volume":"276","author":[{"given":"Zhigao","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9804-4869","authenticated-orcid":false,"given":"Eleni","family":"Samaridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Jaumain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Co\u00ebne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Ullio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Dur\u00e1n-Lobato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulay","family":"Tovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel J.","family":"Santander-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Victoria","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Mar","family":"Arroyo-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Ramos-Membrive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Pe\u00f1uelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alo\u00efse","family":"Mabondzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Pr\u00e9at","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Teixid\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-9567","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.03.004_bb0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0010","series-title":"Reference Module in Chemistry, Molecular Sciences and Chemical Engineering","article-title":"Orally delivered peptides for treatment of inflammatory bowel disease","author":"Smythe","year":"2016"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.addr.2016.04.014","article-title":"Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier","volume":"106","author":"Beloqui","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.addr.2016.03.011","article-title":"How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?","volume":"106","author":"Malhaire","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.addr.2016.04.001","article-title":"Lipid-based nanocarriers for oral peptide delivery","volume":"106","author":"Niu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.addr.2016.02.004","article-title":"Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials","volume":"106","author":"Aguirre","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.addr.2016.04.031","article-title":"Using peptides to increase transport across the intestinal barrier","volume":"106","author":"S\u00e1nchez-Navarro","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2006.12.022","article-title":"A novel approach using functional peptides for efficient intestinal absorption of insulin","volume":"118","author":"Morishita","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2008.08.001","article-title":"Usefulness of cell-penetrating peptides to improve intestinal insulin absorption","volume":"132","author":"Kamei","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2337\/diab.37.2.246","article-title":"New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier","volume":"37","author":"Damg\u00e9","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0168-3659(90)90013-J","article-title":"Nanocapsules as carriers for oral peptide delivery","volume":"13","author":"Damg\u00e9","year":"1990","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0060","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/bm401580k","article-title":"Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration","volume":"15","author":"Agrawal","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-3659(02)00411-X","article-title":"Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats","volume":"86","author":"Takeuchi","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0070","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1016\/j.biomaterials.2014.07.026","article-title":"The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium","volume":"35","author":"Araujo","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2004.07.030","article-title":"Transmucosal macromolecular drug delivery","volume":"101","author":"Prego","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0080","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11095-006-9570-8","article-title":"Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery","volume":"23","author":"Prego","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0085","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1016\/j.biomaterials.2013.07.021","article-title":"Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT","volume":"34","author":"Chuang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0090","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1016\/j.biomaterials.2010.05.042","article-title":"Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0095","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2217\/nnm.12.31","article-title":"Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin","volume":"7","author":"Jain","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1166\/jbn.2009.022","article-title":"Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization","volume":"5","author":"Santander-Ortega","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jps.20750","article-title":"Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery","volume":"96","author":"Cui","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0939-6411(03)00145-0","article-title":"Development of acrylic-based copolymers for oral insulin delivery","volume":"57","author":"Foss","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2004.03.008","article-title":"Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption","volume":"97","author":"Morishita","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0168-3659(02)00028-7","article-title":"Preparation of stable insulin-loaded nanospheres of poly(ethylene glycol) macromers and N-isopropyl acrylamide","volume":"80","author":"Leobandung","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0125","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2217\/nnm.12.141","article-title":"Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle\u2013double emulsion method via the combined use of different solid lipids","volume":"8","author":"Chen","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0130","first-page":"743","article-title":"Oral insulin delivery by means of solid lipid nanoparticles","volume":"2","author":"Sarmento","year":"2007","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0135","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.crohns.2014.02.024","article-title":"Nanotechnology in the treatment of inflammatory bowel diseases","volume":"8","author":"Viscido","year":"2014","journal-title":"J. Crohn's Colitis"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0140","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","article-title":"Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue","volume":"11","author":"Hua","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2015.37","article-title":"Nanomedicines in gastroenterology and hepatology","volume":"12","author":"Lamprecht","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0150","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s11095-013-1233-y","article-title":"Improving the stability and activity of oral therapeutic enzymes\u2014recent advances and perspectives","volume":"31","author":"Fuhrmann","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0155","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nchem.2629","article-title":"Materials and methods for delivery of biological drugs","volume":"8","author":"Zelikin","year":"2016","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0927-7765(99)00157-5","article-title":"The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration","volume":"18","author":"Tobio","year":"2000","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0170","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2014.10.026","article-title":"Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse","volume":"197","author":"Maisel","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0180","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2009.12.011","article-title":"Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery","volume":"143","author":"Lee","year":"2010","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0190","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/02652040903515490","article-title":"Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation","volume":"27","author":"Sun","year":"2010","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0195","doi-asserted-by":"crossref","first-page":"12080","DOI":"10.1039\/c2sm26389k","article-title":"Hydration forces as a tool for the optimization of core-shell nanoparticle vectors for cancer gene therapy","volume":"8","author":"Santander-Ortega","year":"2012","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0200","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2010.05.004","article-title":"Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography","volume":"146","author":"Kamei","year":"2010","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0205","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2017.02.024","article-title":"Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers","volume":"263","author":"Niu","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0215","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1021\/acs.langmuir.7b00351","article-title":"PEGylated nanoemulsions for oral delivery: role of the inner core on the final fate of the formulation","volume":"33","author":"Santander-Ortega","year":"2017","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2004.06.001","article-title":"Real-time multiple-particle tracking: applications to drug and gene delivery","volume":"57","author":"Suh","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0225","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2217\/nnm.14.43","article-title":"Single-particle tracking for studying nanomaterial dynamics: applications and fundamentals in drug delivery","volume":"9","author":"Zagato","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0230","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \"slip\" through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0235","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s13346-011-0048-9","article-title":"Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid)","volume":"2","author":"Yu","year":"2012","journal-title":"Drug Deliv. Trans. Res."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0240","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejpb.2014.12.021","article-title":"In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration","volume":"97","author":"Inchaurraga","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0245","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jecm.2012.06.013","article-title":"Cell-penetrating peptide-biodrug strategy for oral and nasal delivery: review of recent findings","volume":"4","author":"Khafagy","year":"2012","journal-title":"J. Exp. Clin. Med."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0250","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2009.02.015","article-title":"Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide\/protein absorption using cell-penetrating peptides","volume":"136","author":"Kamei","year":"2009","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0255","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2174\/1568026614666140329231718","article-title":"Optimisation of synthetic vector systems for cancer gene therapy - the role of the excess of cationic dendrimer under physiological conditions","volume":"14","author":"Santander-Ortega","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0260","first-page":"3333","article-title":"Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin","volume":"7","author":"Zhang","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0265","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1021\/bc800068h","article-title":"Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain","volume":"19","author":"Koppelhus","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0270","series-title":"Bioconjugation Protocols: Strategies and Methods","first-page":"209","article-title":"Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain","author":"Shiraishi","year":"2011"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0275","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijpharm.2015.09.006","article-title":"Fatty acid modified octa-arginine for delivery of siRNA","volume":"495","author":"Li","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0280","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1261\/rna.2252206","article-title":"Stearylated octaarginine and artificial virus-like particles for transfection of siRNA into primary rat neurons","volume":"12","author":"Tonges","year":"2006","journal-title":"RNA"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0285","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejps.2005.02.008","article-title":"A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery","volume":"25","author":"Garcia-Fuentes","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0290","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00396-009-2131-z","article-title":"Protein-loaded PLGA\u2013PEO blend nanoparticles: encapsulation, release and degradation characteristics","volume":"288","author":"Santander-Ortega","year":"2009","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0295","article-title":"Endocytic trafficking of nanoparticles delivered by cell-penetrating peptides comprised of Nona-arginine and a penetration accelerating sequence","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0300","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1021\/acs.langmuir.5b01226","article-title":"Biocompatible polymeric nanoparticles as promising candidates for drug delivery","volume":"31","author":"Lukasiewicz","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0305","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jconrel.2013.05.035","article-title":"Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus","volume":"170","author":"Xu","year":"2013","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0310","unstructured":"D.R. Thakker, P.D. Ward, Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers, in, US Patent, 2010."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0315","unstructured":"K.I. Cumming, Z. Ramtoola, Solid oral dosage form containing an enhancer, in, US Patent, 2010."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0320","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0169-409X(01)00184-3","article-title":"Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas","volume":"50","author":"Florence","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0325","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000197947","article-title":"Transit time changes with age in the gastrointestinal tract of the rat","volume":"14","author":"Varga","year":"1976","journal-title":"Digestion"},{"key":"10.1016\/j.jconrel.2018.03.004_bb0330","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0278-6915(00)00136-8","article-title":"Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats","volume":"39","author":"DeSesso","year":"2001","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2018.03.004_bb0335","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0065-7743(08)00021-3","article-title":"Contrasting the gastrointestinal tracts of mammals: factors that influence absorption","volume":"43","author":"DeSesso","year":"2008","journal-title":"Ann. Rep. Med. Chem."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918301251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918301251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T03:21:48Z","timestamp":1589858508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918301251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":67,"alternative-id":["S0168365918301251"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.03.004","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}